Henry Schein completes acquisition of majority interest in TriMed

Henry Schein announced it has completed the acquisition of TriMed, developer of solutions for the orthopedic treatment of lower extremities and upper extremities. Headquartered in Santa Clarita, CA, TriMed had 2023 net sales of approximately $52M. Henry Schein expects the transaction to be neutral to 2024 non-GAAP earnings per share and accretive thereafter. Financial terms were not disclosed.